
BioFire Diagnostics—now part of bioMérieux—leverages over 25 years of molecular expertise to set the benchmark in infectious disease diagnostics. The company specializes in syndromic testing, delivering rapid, multiplex PCR solutions through its flagship BioFire® FilmArray® System, which is FDA‑cleared and CE‑IVD marked for a broad spectrum of pathogens. By combining real‑time PCR instruments, high‑resolution melting kits, and antimicrobial resistance gene panels, BioFire provides clinicians with fast, definitive answers that guide optimal therapy. This focus on speed, comprehensiveness, and regulatory compliance positions BioFire as a leader in molecular diagnostics and an attractive workplace for innovators in healthcare technology.
The Disease State Scientist plays a central role in setting up the clinical research agenda to generate clinical and patient outcomes evidence that demonstrates the medical value of our solutions. This role will take the lead on organizing evidence needs into a strategic plan and requires the proven ability to drive clinical research to its completion.
BioFire Diagnostics—now part of bioMérieux—leverages over 25 years of molecular expertise to set the benchmark in infectious disease diagnostics. The company specializes in syndromic testing, delivering rapid, multiplex PCR solutions through its flagship BioFire® FilmArray® System, which is FDA‑cleared and CE‑IVD marked for a broad spectrum of pathogens. By combining real‑time PCR instruments, high‑resolution melting kits, and antimicrobial resistance gene panels, BioFire provides clinicians with fast, definitive answers that guide optimal therapy. This focus on speed, comprehensiveness, and regulatory compliance positions BioFire as a leader in molecular diagnostics and an attractive workplace for innovators in healthcare technology.